Bi Asset Management Fondsmaeglerselskab A Abb Vie Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

$5.3 Billion
Q1 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Abb Vie Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 179,770 shares of ABBV stock, worth $30.8 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

179,770

Previous 213,036 15.62%

Holding current value

$30.8 Million

Previous $33 Million 0.84%

% of portfolio

0.62%

Previous 0.7%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $5.32 Million - $6.06 Million	-33,266 Reduced 15.62%	179,770 $32.7 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $1.13 Million - $1.27 Million	-8,189 Reduced 3.7%	213,036 $33 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $2.27 Million - $2.63 Million	16,994 Added 8.32%	221,225 $33 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $2.99 Million - $3.72 Million	22,566 Added 12.42%	204,231 $27.5 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $331,446 - $381,709	-2,292 Reduced 1.25%	181,665 $29 Million

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $5.26 Million - $6.31 Million	38,047 Added 26.08%	183,957 $29.7 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $293,114 - $336,183	2,184 Added 1.52%	145,910 $19.6 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $81,883 - $104,101	-595 Reduced 0.41%	143,726 $22 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $5.18 Million - $6.43 Million	39,267 Added 37.38%	144,321 $23.4 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $1.71 Million - $2.16 Million	-15,926 Reduced 13.16%	105,054 $14.2 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $7.38 Million - $8.38 Million	69,399 Added 134.54%	120,980 $13.1 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $136,562 - $152,138	-1,298 Reduced 2.45%	51,581 $5.81 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $6.83 Million - $7.52 Million	-66,780 Reduced 55.81%	52,879 $5.72 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $4.44 Million - $6 Million	-55,197 Reduced 31.57%	119,659 $12.8 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $2.75 Million - $3.22 Million	31,980 Added 22.38%	174,856 $15.3 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $122,748 - $164,255	1,673 Added 1.18%	142,876 $14 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $5.53 Million - $8.39 Million	85,779 Added 154.77%	141,203 $10.8 Million
Q4 2019 Mar 19, 2020	BUY	$72.13 - $90.25 $3.5 Million - $4.38 Million	48,478 Added 697.93%	55,424 $4.91 Million
Q3 2019 Mar 19, 2020	SELL	$62.98 - $75.72 $27,711 - $33,316	-440 Reduced 5.96%	6,946 $526,000
Q2 2019 Mar 19, 2020	BUY	$65.7 - $83.98 $485,260 - $620,276	7,386 New	7,386 $537,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Abb Vie Inc. Transaction History